RECOMBINANT HUMAN ERYTHROPOIETIN IN NEPHROLOGY

被引：2
作者：
SAMTLEBEN, W
IVANOVICH, P
GURLAND, HJ
机构：
[1] LAKESIDE VET ADM MED CTR, CHICAGO, IL 60611 USA
[2] NORTHWESTERN UNIV, SCH MED, CHICAGO, IL 60611 USA
来源：
BIOMEDICINE & PHARMACOTHERAPY | 1989年 / 43卷 / 08期
关键词：
D O I：
10.1016/0753-3322(89)90039-5
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：607 / 612
页数：6
相关论文
共 44 条
[1]  
Bocker A, 1988, Contrib Nephrol, V66, P165
[2]  
BOMMER J, 1987, LANCET, V1, P392
[3]  
BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238
[4]  
BOMMER J, 1988, LANCET, V2, P406
[5]  
Bommer J, 1988, Contrib Nephrol, V66, P85
[6]  
CARO J, 1979, J LAB CLIN MED, V93, P449
[7]  
CARO J, 1988, CONTRIB NEPHROL, V66
[8]   BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].
CASATI, S ;
PASSERINI, P ;
CAMPISE, MR ;
GRAZIANI, G ;
CESANA, B ;
PERISIC, M ;
PONTICELLI, C .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020
[9]  
DELANO BG, 1988, KIDNEY INT, V33, P219
[10]  
ESCHBACH JW, 1987, NEW ENGL J MED, V317, P250
12345